UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended December 25, 2010

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 000-10030

Apple Inc.

(Exact name of Registrant as specified in its charter)

California

94-2404110

(State or other jurisdiction

of incorporation or organization)

(I.R.S. Employer Identification No.)

1 Infinite Loop

Cupertino, California

95014

(Address of principal executive offices)

(Zip Code)

Registrant s telephone number, including area code: (408) 996-1010

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the

Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes No

Indicate by check mark whether the registrant has submitted electronically

and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T ( 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the

registrant was required to submit and post such files).

Yes No

Indicate by check mark whether the registrant is a large accelerated filer,

an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

(Do not check if a smaller reporting company)

Smaller reporting company

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes No

921,278,012 shares of common stock issued and outstanding as of January 7, 2011

PART I. FINANCIAL INFORMATION

Item 1.

Financial Statements

APPLE INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

(in millions, except share amounts which are reflected in thousands and per share amounts)

Three Months Ended

December 25,

2010

December 26,

2009

Net sales

26,741

15,683

Cost of sales

16,443

9,272

Gross margin

10,298

6,411

Operating expenses:

Research and development

575

398

Selling, general and administrative

1,896

1,288

Total operating expenses

2,471

1,686

Operating income

7,827

4,725

Other income and expense

136

33

Income before provision for income taxes

7,963

4,758

Provision for income taxes

1,959

1,380

Net income

6,004

3,378

Earnings per common share:

Basic

6.53

3.74

Diluted

6.43

3.67

Shares used in computing earnings per share:

Basic

919,294

903,542

Diluted

933,154

919,783

See accompanying Notes

to Condensed Consolidated Financial Statements.

APPLE INC.

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

(in millions, except

share amounts)

December 25,

2010

September 25,

2010

ASSETS:

Current assets:

Cash and cash equivalents

10,734

11,261

Short-term marketable securities

16,243

14,359

Accounts receivable, less allowances of $62 and $55, respectively

6,027

5,510

Inventories

885

1,051

Deferred tax assets

1,724

1,636

Vendor non-trade receivables

4,847

4,414

Other current assets

3,467

3,447

Total current assets

43,927

41,678

Long-term marketable securities

32,730

25,391

Property, plant and equipment, net

5,868

4,768

Goodwill

741

741

Acquired intangible assets, net

522

342

Other assets

2,954

2,263

Total assets

86,742

75,183

LIABILITIES AND SHAREHOLDERS EQUITY:

Current liabilities:

Accounts payable

14,301

12,015

Accrued expenses

5,953

5,723

Deferred revenue

3,541

2,984

Total current liabilities

23,795

20,722

Deferred revenue non-current

1,216

1,139

Other non-current liabilities

7,065

5,531

Total liabilities

32,076

27,392

Commitments and contingencies

Shareholders equity:

Common stock, no par value; 1,800,000,000 shares authorized; 921,035,475 and 915,970,050 shares issued and outstanding,

respectively

11,502

10,668

Retained earnings

43,050

37,169

Accumulated other comprehensive income/(loss)

114

(46

Total shareholders equity

54,666

47,791

Total liabilities and shareholders equity

86,742

75,183

See accompanying Notes to Condensed Consolidated Financial Statements.

APPLE INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

(in millions)

Three Months Ended

December 25,

2010

December 26,

2009

Cash and cash equivalents, beginning of the period

11,261

5,263

Operating activities:

Net income

6,004

3,378

Adjustments to reconcile net income to cash generated by operating activities:

Depreciation, amortization and accretion

356

209

Stock-based compensation expense

299

205

Deferred income tax expense

823

425

Changes in operating assets and liabilities:

Accounts receivable, net

(517

271

Inventories

166

(121

Vendor non-trade receivables

(433

(95

Other current and non-current assets

(558

(369

Accounts payable

2,346

956

Deferred revenue

634

606

Other current and non-current liabilities

653

316

Cash generated by operating activities

9,773

5,781

Investing activities:

Purchases of marketable securities

(19,575

(12,922

Proceeds from maturities of marketable securities

3,279

6,216

Proceeds from sales of marketable securities

6,853

3,199

Payments for acquisition of property, plant and equipment

(1,214

(376

Payments for acquisition of intangible assets

(49

(5

Other

(23

(70

Cash used in investing activities

(10,729

(3,958

Financing activities:

Proceeds from issuance of common stock

208

374

Excess tax benefits from stock-based compensation

454

252

Taxes paid related to net share settlement of equity awards

(233

(103

Cash generated by financing activities

429

523

(Decrease)/increase in cash and cash equivalents

(527

2,346

Cash and cash equivalents, end of the period

10,734

7,609

Supplemental cash flow disclosure:

Cash paid for income taxes, net

826

980

See accompanying Notes

to Condensed Consolidated Financial Statements.

Apple Inc.

Notes to Condensed Consolidated Financial Statements (Unaudited)

Note 1 Summary of Significant Accounting Policies

Apple Inc. and its wholly-owned subsidiaries (collectively Apple or the Company ) designs, manufactures, and

markets personal computers, mobile communication and media devices, and portable digital music players, and sells a variety of related software, services, peripherals, networking solutions, and third-party digital content and applications. The

Company sells its products worldwide through its retail stores, online stores, and direct sales force, as well as third-party cellular network carriers, wholesalers, resellers and value-added resellers. In addition, the Company sells a variety of

third-party Macintosh ( Mac ), iPhone, iPad and iPod compatible products including application software, printers, storage devices, speakers, headphones, and various other accessories and supplies through its online and retail stores. The

Company sells to consumer, small and mid-sized business, education, enterprise, government and creative markets.

Basis of Presentation and

Preparation

The accompanying condensed consolidated financial statements include the accounts of the Company. Intercompany

accounts and transactions have been eliminated. The preparation of these condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles ( GAAP ) requires management to make estimates and

assumptions that affect the amounts reported in these condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. Certain prior year amounts in the condensed consolidated financial

statements and notes thereto have been reclassified to conform to the current period s presentation.

These condensed

consolidated financial statements and accompanying notes should be read in conjunction with the Company s annual consolidated financial statements and the notes thereto for the fiscal year ended September 25, 2010, included in its Annual

Report on Form 10-K (the 2010 Form 10-K ). Unless otherwise stated, references to particular years or quarters refer to the Company s fiscal years ended in September and the associated quarters of those fiscal years.

During the first quarter of 2011, the Company adopted the Financial Accounting Standard Board s ( FASB ) new accounting

standard on consolidation of variable interest entities. This new accounting standard eliminates the mandatory quantitative approach in determining control for evaluating whether variable interest entities need to be

consolidated in favor of a qualitative analysis, and requires an ongoing reassessment of control over such entities. The adoption of this new accounting standard did not impact the Company s condensed consolidated financial

statements.

Earnings Per Common Share

Basic earnings per common share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per

common share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period increased to include the number of additional shares of common stock that would have

been outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding options, shares to be purchased under the employee stock purchase plan, and unvested restricted stock units

( RSUs ). The dilutive effect of potentially dilutive securities is reflected in diluted earnings per common share by application of the treasury stock method. Under the treasury stock method, an increase in the fair market value of the

Company s common stock can result in a greater dilutive effect from potentially dilutive securities.

The following table sets forth the computation of basic and diluted earnings per common

share for the three months ended December 25, 2010 and December 26, 2009 (in thousands, except net income in millions and per share amounts):

Three Months Ended

December 25,

2010

December 26,

2009

Numerator:

Net income

6,004

3,378

Denominator:

Weighted-average shares outstanding

919,294

903,542

Effect of dilutive securities

13,860

16,241

Weighted-average diluted shares

933,154

919,783

Basic earnings per common share

6.53

3.74

Diluted earnings per common share

6.43

3.67

Potentially dilutive

securities representing approximately 83,000 shares and 1.8 million shares of common stock for the quarters ended December 25, 2010 and December 26, 2009, respectively, were excluded from the computation of diluted earnings per common

share for these periods because their effect would have been antidilutive.

Note 2 Financial Instruments

Cash, Cash Equivalents and Marketable Securities

The following tables

summarize the Company s available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category recorded as cash and cash equivalents or short-term or long-term

marketable securities as of December 25, 2010 and September 25, 2010 (in millions):

December 25, 2010

Adjusted

Cost

Unrealized

Gains

Unrealized

Losses

Fair

Value

Cash and

Cash

Equivalents

Short-Term

Marketable

Securities

Long-Term

Marketable

Securities

Cash

3,000

3,000

3,000

Money market funds

1,470

1,470

1,470

U.S. Treasury securities

8,368

16

(23

8,361

1,537

2,112

4,712

U.S. agency securities

10,821

(10

10,818

1,200

4,467

5,151

Non-U.S. government securities

4,328

11

(4

4,335

1,318

3,008

Certificates of deposit and time deposits

3,639

(1

3,639

1,342

943

1,354

Commercial paper

3,871

3,871

2,134

1,737

Corporate securities

21,704

72

(35

21,741

39

5,283

16,419

Municipal securities

2,474

(9

2,472

383

2,086

Total cash, cash equivalents and marketable securities

59,675

114

(82

59,707

10,734

16,243

32,730

September 25, 2010

Adjusted

Cost

Unrealized

Gains

Unrealized

Losses

Fair

Value

Cash and

Cash

Equivalents

Short-Term

Marketable

Securities

Long-Term

Marketable

Securities

Cash

1,690

1,690

1,690

Money market funds

2,753

2,753

2,753

U.S. Treasury securities

9,872

42

9,914

2,571

2,130

5,213

U.S. agency securities

8,717

10

8,727

1,916

4,339

2,472

Non-U.S. government securities

2,648

13

2,661

10

865

1,786

Certificates of deposit and time deposits

2,735

(1

2,739

374

850

1,515

Commercial paper

3,168

3,168

1,889

1,279

Corporate securities

17,349

102

(9

17,442

58

4,522

12,862

Municipal securities

1,899

19

(1

1,917

374

1,543

Total cash, cash equivalents and marketable securities

50,831

191

(11

51,011

11,261

14,359

25,391

The Company had net unrealized gains on its investment portfolio of $32 million and $180 million as of

December 25, 2010 and September 25, 2010, respectively. The net unrealized gains as of December 25, 2010 and September 25, 2010 related primarily to long-term marketable securities. The Company may sell certain of its marketable

securities prior to their stated maturities for strategic purposes for reasons, including but not limited to, anticipation of credit deterioration and duration management. The Company recognized no significant net realized gains or losses during the

first quarter of 2011 or 2010 related to such sales. The maturities of the Company s long-term marketable securities generally range from one year to five years.

As of December 25, 2010, the Company had $1 million of gross unrealized losses related to individual securities that had been in a continuous loss position for 12 months or longer. The fair value of

the individual securities that had been in a continuous loss position for 12 months or longer as of December 25, 2010 was $518 million. The Company had $11 million of gross unrealized losses as of September 25, 2010, of which an

insignificant amount had been in a continuous loss position for 12 months or longer.

The Company considers the declines in

market value of its marketable securities investment portfolio to be temporary in nature. The Company typically invests in highly-rated securities, and its policy generally limits the amount of credit exposure to any one issuer. The Company s

investment policy requires investments to be investment grade, primarily rated single-A or better, with the objective of minimizing the potential risk of principal loss. Fair values were determined for each individual security in the investment

portfolio. When evaluating the investments for other-than-temporary impairment, the Company reviews factors such as the length of time and extent to which fair value has been below cost basis, the financial condition of the issuer and any changes

thereto, and the Company s intent to sell, or whether it is more likely than not it will be required to sell, the investment before recovery of the investment s amortized cost basis. During the first quarters of 2011 and 2010, the Company

did not recognize any significant impairment charges. As of December 25, 2010, the Company does not consider any of its investments to be other-than-temporarily impaired.

Derivative Financial Instruments

The Company uses derivatives to partially

offset its business exposure to foreign currency exchange risk. The Company may enter into foreign currency forward and option contracts to offset some of the foreign exchange risk of expected future cash flows on certain forecasted revenue and cost

of sales, of net investments in certain foreign subsidiaries, and on certain existing assets and liabilities. To help protect gross margins from fluctuations in foreign currency exchange rates, certain of the Company s subsidiaries whose

functional currency is the U.S. dollar hedge a portion of forecasted foreign currency revenue. The Company s subsidiaries whose functional currency is not the U.S. dollar and who sell in local currencies may hedge a portion of forecasted

inventory purchases not denominated in the subsidiaries functional currencies. The Company typically hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases for three to six months. To help

protect the net investment in a foreign operation from adverse changes in foreign currency exchange rates, the Company may enter into foreign currency forward and option contracts to offset the changes in the carrying amounts of these investments

due to fluctuations in foreign currency exchange rates. The Company may also enter into foreign currency forward and option contracts to partially offset the foreign currency exchange gains and losses generated by the re-measurement of certain

assets and liabilities denominated in non-functional currencies. However, the Company may choose not to hedge certain foreign currency exchange exposures for a variety of reasons, including but not limited to immateriality, accounting considerations

and the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency exchange rates.

The Company s accounting policies for these instruments are based on whether the

instruments are designated as hedge or non-hedge instruments. The Company records all derivatives on the Condensed Consolidated Balance Sheets at fair value. The effective portions of cash flow hedges are recorded in other comprehensive income until

the hedged item is recognized in earnings. The effective portions of net investment hedges are recorded in other comprehensive income as a part of the cumulative translation adjustment. Derivatives that are not designated as hedging instruments and

the ineffective portions of cash flow hedges and net investment hedges are adjusted to fair value through earnings in other income and expense.

The Company had a net deferred loss associated with cash flow hedges of approximately $9 million and $252 million, net of taxes, recorded in other comprehensive income as of December 25, 2010 and

September 25, 2010, respectively. Other comprehensive income associated with cash flow hedges of foreign currency revenue is recognized as a component of net sales in the same period as the related revenue is recognized, and other comprehensive

income related to cash flow hedges of inventory purchases is recognized as a component of cost of sales in the same period as the related costs are recognized. Substantially all of the Company s hedged transactions as of December 25, 2010

are expected to occur within six months.

Derivative instruments designated as cash flow hedges must be de-designated as

hedges when it is probable the forecasted hedged transaction will not occur in the initially identified time period or within a subsequent two-month time period. Deferred gains and losses in other comprehensive income associated with such derivative

instruments are reclassified immediately into earnings through other income and expense. Any subsequent changes in fair value of such derivative instruments also are reflected in current earnings unless they are re-designated as hedges of other

transactions. The Company did not recognize any material net gains or losses related to the loss of hedge designation on discontinued cash flow hedges during the first quarter of 2011 or 2010.

The Company had an unrealized net gain on net investment hedges of $3 million and an unrealized net loss on net investment hedges of $9

million, net of taxes, included in the cumulative translation adjustment account of accumulated other comprehensive income ( AOCI ) as of December 25, 2010 and September 25, 2010, respectively. The ineffective portions and

amounts excluded from the effectiveness test of net investment hedges are recorded in current earnings in other income and expense.

The Company recognized in earnings a net gain of $29 million and a net loss of $34 million on foreign currency forward and option contracts not designated as hedging instruments during the first quarter

of 2011 and 2010, respectively. These amounts represent the net gain or loss on the derivative contracts and do not include changes in the related exposures, which generally offset a portion of the gain or loss on the derivative contracts.

The following table shows the notional principal amounts of the Company s outstanding derivative instruments and credit

risk amounts associated with outstanding or unsettled derivative instruments as of December 25, 2010 and September 25, 2010 (in millions):

December 25, 2010

September 25, 2010

Notional

Principal

Credit

Risk

Amounts

Notional

Principal

Credit

Risk

Amounts

Instruments qualifying as accounting hedges:

Foreign exchange contracts

11,193

113

13,957

62

Instruments other than accounting hedges:

Foreign exchange contracts

10,613

82

10,727

45

The notional principal amounts for outstanding derivative instruments provide one measure of

the transaction volume outstanding and does not represent the amount of the Company s exposure to credit or market loss. The credit risk amounts represent the Company s gross exposure to potential accounting loss on derivative instruments

that are outstanding or unsettled if all counterparties failed to perform according to the terms of the contract, based on then-current currency exchange rates at each respective date. The Company s gross exposure on these transactions may be

further mitigated by collateral received from certain counterparties. The Company s exposure to credit loss and market risk will vary over time as a function of currency exchange rates. Although the table above reflects the notional principal

and credit risk amounts of the Company s foreign exchange instruments, it does not reflect the gains or losses associated with the exposures and transactions that the foreign exchange instruments are intended to hedge. The amounts ultimately

realized upon settlement of these financial instruments, together with the gains and losses on the underlying exposures, will depend on actual market conditions during the remaining life of the instruments.

The Company generally enters into master netting arrangements, which reduce credit risk by permitting net settlement of transactions with

the same counterparty. To further limit credit risk, the Company generally enters into collateral security arrangements that provide for collateral to be received or posted when the net fair value of certain financial instruments fluctuates from

contractually established thresholds. The Company presents its derivative assets and derivative liabilities at their gross fair values. As of December 25, 2010, the Company received cash collateral related to the derivative instruments under

its collateral security arrangements of $77 million and recorded the offsetting balance as accrued expenses in the Condensed Consolidated Balance Sheet. As of September 25, 2010, the Company posted cash collateral related to the derivative

instruments under its collateral security arrangements of $445 million and recorded the offsetting balance as other current assets in the Condensed Consolidated Balance Sheet. The Company did not have any derivative instruments with credit

risk-related contingent features that would require it to post additional collateral as of December 25, 2010 or September 25, 2010.

The estimates of fair value are based on applicable and commonly used pricing models and prevailing financial market information as of December 25, 2010 and September 25, 2010. Refer to Note 3,

Fair Value Measurements of this Form 10-Q, for additional information on the fair value measurements for all financial assets and liabilities, including derivative assets and derivative liabilities, that are measured at fair value in the

condensed consolidated financial statements on a recurring basis. The following tables show the Company s derivative instruments measured at gross fair value as reflected in the Condensed Consolidated Balance Sheets as of December 25, 2010

and September 25, 2010 (in millions):

December 25, 2010

Fair Value of

Derivatives

Designated as

Hedge Instruments

Fair Value of

Derivatives Not

Designated as

Hedge Instruments

Total

Fair Value

Derivative assets (a):

Foreign exchange contracts

112

82

194

Derivative liabilities (b):

Foreign exchange contracts

87

21

108

September 25, 2010

Fair Value of

Derivatives

Designated as

Hedge Instruments

Fair Value of

Derivatives Not

Designated as

Hedge Instruments

Total

Fair Value

Derivative assets (a):

Foreign exchange contracts

62

45

107

Derivative liabilities (b):

Foreign exchange contracts

488

118

606

(a)

All derivative assets are recorded as other current assets in the Condensed Consolidated Balance Sheets.

(b)

All derivative liabilities are recorded as accrued expenses in the Condensed Consolidated Balance Sheets.

The following table shows the pre-tax effect of the Company s derivative instruments

designated as cash flow and net investment hedges in the Condensed Consolidated Statements of Operations for the three months ended December 25, 2010 and December 26, 2009 (in millions):

Gains/(Losses) Recognized in

OCI - Effective Portion (c)

Gains/(Losses) Reclassified

from AOCI into Income -

Effective Portion (c)

Gains/(Losses) Recognized -

Ineffective

Portion and Amount Excluded from

Effectiveness Testing

December 25,

2010

December 26,

2009

December 25,

2010 (a)

December 26,

2009 (b)

Location

December 25,

2010

December 26,

2009

Cash flow hedges:

Foreign exchange contracts

(66

12

(449

(20

Other income

and expense

21

(14

Net investment hedges:

Foreign exchange contracts

(3

(1

Other income

and expense

Total

(69

11

(449

(20

21

(14

(a)

Includes gains/(losses) reclassified from AOCI into net income for the effective portion of cash flow hedges, of which $(257) million and $(192)

million were recognized within net sales and cost of sales, respectively, within the Condensed Consolidated Statement of Operations for the three months ended December 25, 2010. There were no amounts reclassified from AOCI into net income for

the effective portion of net investment hedges for the three months ended December 25, 2010.

(b)

Includes gains/(losses) reclassified from AOCI into net income for the effective portion of cash flow hedges, of which $2 million and ($22) million

were recognized within net sales and cost of sales, respectively, within the Condensed Consolidated Statement of Operations for the three months ended December 26, 2009. There were no amounts reclassified from AOCI into net income for the

effective portion of net investment hedges for the three months ended December 26, 2009.

(c)

Refer to Note 6, Shareholders Equity and Stock-Based Compensation of this Form 10-Q, which summarizes the activity in AOCI related

to derivatives.

Accounts Receivable

The Company has considerable trade receivables not covered by collateral, third-party financing arrangements or credit insurance outstanding with its third-party cellular network carriers, wholesalers,

retailers, and value-added resellers, and directly to certain education, consumer and enterprise customers. There was one customer that represented 10% of the Company s trade receivables as of December 25, 2010. Trade receivables from two

of the Company s customers accounted for 15% and 12% of trade receivables as of September 25, 2010. The Company s cellular network carriers accounted for 54% and 64% of trade receivables as of December 25, 2010 and

September 25, 2010, respectively. Additionally, the Company has non-trade receivables from certain of its manufacturing vendors. Vendor non-trade receivables from two of the Company s vendors accounted for 55% and 27%, respectively, of

non-trade receivables as of December 25, 2010 and two of the Company s vendors accounted for 57% and 24%, respectively, of non-trade receivables as of September 25, 2010.

10

Note 3 Fair Value Measurements

The Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When

determining the fair value measurements for assets and liabilities, which are required to be recorded at fair value, the Company considers the principal or most advantageous market in which the Company would transact and the market-based risk

measurements or assumptions that market participants would use in pricing the asset or liability, such as inherent risk, transfer restrictions and credit risk.

The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of

input that is available and significant to the fair value measurement:

Level 1 Quoted prices in active markets

for identical assets or liabilities.

Level 2 Observable inputs other than quoted prices in active markets for

identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or

liabilities.

Level 3 Inputs that are generally unobservable and typically reflect management s estimates

of assumptions that market participants would use in pricing the asset or liability.

The Company s valuation techniques

used to measure the fair value of money market funds and certain marketable equity securities were derived from quoted prices in active markets for identical assets or liabilities. The valuation techniques used to measure the fair value of all other

financial instruments, all of which have counterparties with high credit ratings, were valued based on quoted market prices or model driven valuations using significant inputs derived from or corroborated by observable market data.

Assets and Liabilities Measured at Fair Value

The following tables present the Company s assets and liabilities measured at fair value, which also represents the related carrying amounts, on a recurring basis as of December 25, 2010 and

September 25, 2010 (in millions):

Quoted Prices in Active

Markets for Identical

Instruments

(Level 1)

Significant

Other

Observable Inputs

(Level 2)

Significant

Unobservable

Inputs

(Level 3)

Total

December 25,

2010

September 25,

2010

December 25,

2010

September 25,

2010

December 25,

2010

September 25,

2010

December 25,

2010

September 25,

2010

Assets:

Money market funds

1,470

2,753

1,470

2,753

U.S. Treasury securities

8,361

9,914

8,361

9,914

U.S. agency securities

10,818

8,727

10,818

8,727

Non-U.S. government securities

4,335

2,661

4,335

2,661

Certificates of deposit and time deposits

3,639

2,739

3,639

2,739

Commercial paper

3,871

3,168

3,871

3,168

Corporate securities

21,741

17,442

21,741

17,442

Municipal securities

2,472

1,917

2,472